Journal of Guangdong University of Technology ›› 2020, Vol. 37 ›› Issue (03): 95-100.doi: 10.12052/gdutxb.190070
Previous Articles Next Articles
Xiao Qing-wei, Chang Yuan-yuan, Liu Qi-fa, Zang Xiao-hao, Hu Meng-meng, Zhou Wei
CLC Number:
[1] TORRE L A, BRAY F, SIEGEL R L, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108 [2] SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30 [3] CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA: A Cancer Journal for Clinicians, 2016, 66(2): 115-132 [4] 贺晓鹏. 分子探针:提速癌症诊断的新工具[J]. 世界复合医学, 2015, 1(3): 207-211 HE X P. Molecular probes: new-generation tools for the accelerated diagnosis of cancer [J]. World Journal of Complex Medicine, 2015, 1(3): 207-211 [5] 韩雪迪. 前列腺特异性膜抗原靶向分子探针在前列腺癌诊断及治疗中的应用[J]. 中国医学影像学杂志, 2016, 24(10): 790-792 [6] MHAWECH-FAUCEGLIA P, ZHANG S, TERRACCIANO L, et al. Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique [J]. Histopathology, 2010, 50(4): 472-483 [7] KIESS A P, BANERJEE S R, MEASE R C, et al. Prostate-specific membrane antigen as a target for cancer imaging and therapy [J]. The quarterly journal of nuclear medicine and molecular imaging, 2015, 59(3): 241-268 [8] TSUKAMOTO T, WOZNIAK K M, SLUSHER B S. Progress in the discovery and development of glutamate carboxypeptidase Ⅱ inhibitors [J]. Drug Discov Today, 2007, 12(17-18): 767-76 [9] BARINKA C, BYUN Y, DUSICH C L, et al. Interactions between human glutamate carboxypeptidase Ⅱ and urea-based inhibitors: structural characterization [J]. Journal of Medicinal Chemistry, 2008, 51(24): 7737-7743 [10] BANERJEE S R, PULLAMBHATLA M, BYUN Y, et al. 68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer [J]. Journal of Medicinal Chemistry, 2010, 53(14): 5333-5341 [11] BANERJEE S R, NGEN E J, ROTZ M W, et al. Synthesis and evaluation of Gd(Ⅲ)-based magnetic resonance contrast agents for molecular imaging of prostate-specific membrane antigen [J]. Angew Chem Int Ed Engl, 2015, 54(37): 10778-10782 [12] FAN W, ZHANG Z, ZHU Z, et al. Synthesis and positron emission tomography evaluation of 18F-Glu-Urea- Lys, a prostate-specific membrane antigen-based imaging agent for prostate cancer [J]. Oncology Letters, 2015, 10(4): 2299-2302 [13] HILLIER S M, MARESCA K P, FEMIA F J, et al. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer [J]. Cancer Res, 2009, 69(17): 6932-6940 [14] BENEŠOVÁ M, BAUDER-WÜST U, SCHÄFER M, et al. Linker modification strategies to control the prostate-specific membrane antigen (PSMA)-targeting and pharmacokinetic properties of DOTA-conjugated PSMA inhibitors [J]. Journal of Medicinal Chemistry, 2016, 59(5): 1761-1775 [15] 陈骁驰, 杨德勇, 车翔宇, 等. PSMA靶向性小分子谷氨酸尿素类似物Glu-Urea-Lys的合成[J]. 大连医科大学学报, 2012, 34(1): 13-17 CHEN X C, YANG D Y, CHE X Y at al. Synthesis of PSMA-targeted small molecule Glu-Urea-Lys analogue [J]. Journal of Dalian Medical University, 2012, 34(1): 13-17 |
No related articles found! |
|